Enosi
Financial Software · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11 York St, Sydney, New South Wales, 200...Website
enosi.energyRevenue
<$5 MillionIndustry
About Enosi
Enosi Org Chart
Is Enosi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Enosi recently announced quarterly report
Check out if Enosi is spiking on competitors!
Check if Enosi has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Enosi has new funding data
Product Launch: Get notified when Enosi launches new products
Click to see if Enosi had a recent Job posting/layoffs
Enosi, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Enosi
Recommended Actions
Reach out to Masked Content who joined Enosi as Masked Content
Find 2 more new buyers
Compare Similar Companies to Enosi
Compare insights from companies similar to Enosi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Enosi is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Enosi is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Enosi.
Enosi Tech Stack
A closer look at the technologies used by Enosi
Enosi News & Media
Enosi Life Sciences Launches Regulation D Offering to Fund Antibody Therapeutics Development
Capital raised from the Regulation D offering will support the continued development of Enosi’s novel “second generation” anti-TNF therapeutics Capital raised from the Regulation D offering will support the continued development of Enosi’s novel “second generation” anti-TNF therapeuticsEnosi Life Sciences’ Sir Marc Feldmann to Join 2020 Tang Prize Masters’ Forum in Biopharmaceutical Science
Named a 2020 Tang Prize Laureate earlier this year, Feldmann will sit on the Masters’ forum alongside fellow recipients to discuss cytokine-targeting therapies for the treatment of inflammatory diseases Named a 2020 Tang Prize Laureate earlier this year, Feldmann will sit on the Masters’ forum alongside fellow recipients to discuss cytokine-targeting therapies for the treatment of inflammatory diseasesEnosi Life Sciences Appoints Biotech, Pharma and Venture Capital Veteran Dr. James N. Woody as Executive Chairman
Dr. James Woody’s leadership qualities and experience leading innovative pharmaceutical ventures and raising funds will power Enosi’s development of second-generation anti-TNF therapeutics for inflammatory autoimmune diseases and cancer.Therapeutic Antibody Pioneers Professor Sir Marc Feldmann and Dr. H. Michael Shepard Formally Launch Enosi Life Sciences
The Company will focus on second generation therapeutics for cancer and autoimmune diseases based on their previous successes The Company will focus on second generation therapeutics for cancer and autoimmune diseases based on their previous successes
Top Financial Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Enosi
Enosi is a company that provides the Powertracer platform, designed for clean energy traceability, allowing users to buy or trade excess solar generation within a community. Their service targets large enterprises like Google, Microsoft, and IBM, as well as households and businesses seeking to reduce electricity costs while accessing 100% carbon-fr... Read More